4519.T

Chugai Pharmaceutical Co., Ltd.
TokyoJPYEQUITY DELAYED
Last price
7,045.00
▼ 56.00 (0.79%)
MARKET ·

Price

Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
7,046.00
Prev close
7,101.00
Day high
7,111.00
Day low
6,996.00
Volume
1.89M
Market cap
P/E (TTM)
52W range
6,002.00 – 10,700.00

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
+1.13% +2.5%
1M
-4.04% -7.8%
3M
-13.34% -16.4%
6M
-24.47% -35.5%
YTD
-14.95% -27.2%
1Y
-5.26% -25.3%
3Y
+79.40% +5.2%
5Y

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Free account

3 more panels on 4519.T open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap
Enterprise value
Revenue (TTM)
Gross profit
EBITDA
Net income
EPS (TTM)
Free cash flow
Total cash
Total debt
Book value / share
Shares outstanding
Float
Short % of float
Dividend yield
Beta (5Y)

Valuation & profitability ratios

Account required
Trailing P/E
Forward P/E
PEG ratio
Price / sales
Price / book
EV / revenue
EV / EBITDA
Gross margin
Operating margin
Profit margin
Return on equity
Return on assets
Debt / equity
Current ratio
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Financial statements

As reported · 4 years · 3 quarters
Blank means not reported, not zero
Line item2025202420232022YoY
Total revenue $1.26T$1.17T$1.11T$1.26T +7.5%
Operating revenue $1.26T$1.17T$1.11T$1.26T +7.5%
Cost of revenue $363.69B$339.41B$413.31B$476.25B +7.2%
Gross profit $894.25B$831.20B$698.06B$783.48B +7.6%
Research & development $187.60B$181.44B$174.87B$149.63B +3.4%
Selling, general & admin $116.46B$110.10B$112.58B$100.48B +5.8%
Total operating expense $295.42B$289.20B$258.89B$250.17B +2.2%
Operating income $598.83B$542.00B$439.17B$533.31B +10.5%
Net interest income -$1.03B$1.03B$4.65B-$9.00M -199.4%
Pre-tax income $597.81B$543.03B$443.82B$531.17B +10.1%
Tax provision $163.79B$155.72B$118.35B$156.74B +5.2%
Net income to common $434.01B$387.32B$325.47B$374.43B +12.1%
Basic EPS 263.73235.39197.83227.64 +12.0%
Diluted EPS 263.72235.36197.80227.57 +12.0%
EBIT $598.01B$542.00B$443.85B$531.23B +10.3%
EBITDA $598.01B$542.00B$443.85B$531.23B +10.3%
Basic shares 1.65B1.65B1.65B1.65B +0.0%
Diluted shares 1.65B1.65B1.65B1.65B +0.0%

Analyst targets & ownership

Account required
Mean target
High target
Low target
Implied upside
Analyst count
Consensus
Strong buy / Buy— / —
Hold
Sell / Strong sell— / —
Held by insiders
Held by institutions
Institutions holding
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
6,996.90
+0.69% from price
SMA 20
6,956.15
+0.79% from price
SMA 50
7,238.54
-3.14% from price
SMA 100
7,718.39
-8.72% from price
SMA 200
8,132.37
-13.79% from price
EMA 12
6,977.90
+0.96% from price
EMA 26
7,054.40
-0.13% from price
EMA 50
7,247.76
-2.80% from price
RSI (14)
48.3
Neutral
MACD (12,26,9)
-76.50
Hist 30.51
ATR (14)
176.43
2.52% of price
Realised vol 30D
35.5%
Annualised
Bollinger upper
7,328.43
20, 2σ
Bollinger lower
6,583.87
20, 2σ
50 / 200 cross
Death
7,238.54 vs 8,132.37
Trend bias
Below 200
-13.79%

Options chain

Account required
ExpirySpot 7,045.00
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
-0.28
Less volatile than market
Correlation to SPY
-0.09
Largely independent
Realised vol 30D
35.5%
Annualised
Market vol 1Y
12.9%
SPY, annualised
Max drawdown 1Y
-36.1%
Peak to trough
Max drawdown 5Y
-36.1%
Peak to trough
ATR 14
176.43
2.52% of price
Beta (reported)
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.